Harnessing the immunomodulatory properties of HLA-G for advanced immunotherapies
Open Access
- 9 December 2025
- journal article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16
Abstract
Human leukocyte antigen-G (HLA-G) is a non-classical MHC class I molecule with unique immunomodulatory properties that extend far beyond its well-established role at the maternal-fetal interface. Increasing evidence highlights HLA-G as a pivotal regulator of immune homeostasis, capable of shaping both innate and adaptive cytotoxic responses. It exerts a context-dependent role, promoting tolerance in settings such as transplantation and autoimmunity while contributing to immune evasion in cancer and infection, and this functional plasticity is further shaped by its isoform diversity and its interplay with other non-classical HLA class I molecules. In this review, we discuss key aspects of HLA-G biology, particularly its capacity to promote immune tolerance or facilitate immune escape, and how these insights can be leveraged in the development of cellular and acellular immunotherapies. We further summarize current strategies that incorporate or target HLA-G in the treatment of malignancies and autoimmune diseases, and highlight its emerging potential as a therapeutic target.Keywords
This publication has 75 references indexed in Scilit:
- Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung CancerAdvanced Science, 2024
- IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-GBreast Cancer, 2023
- BiTE‐Secreting CAR‐γδT as a Dual Targeting Strategy for the Treatment of Solid TumorsAdvanced Science, 2023
- Novel landscape of HLA‐G isoforms expressed in clear cell renal cell carcinoma patientsMolecular Oncology, 2017
- HLA-G2015
- Inhibition of DNA methylation enhances HLA-G expression in human mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2014
- Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptorsCellular and Molecular Life Sciences, 2012
- HLA‐G inhibition of NK‐cell cytolytic function is uncoupled from tumor cell lipid raft reorganizationEuropean Journal of Immunology, 2011
- Down-regulation of HLA-G boosted natural killer cell-mediated cytolysis in JEG-3 cells cultured in vitroFertility and Sterility, 2008
- Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysisBiochemical and Biophysical Research Communications, 2004